BYDUREON (exenatide synthetic) Astrazeneca ab Patent: 9,198,925 Expiration: Oct 4, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of October 4, 2020 Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post New patent expiration for Astrazeneca Ab drug BYDUREON appeared…
New patent expiration for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post New patent expiration for Astrazeneca Ab drug BYDUREON PEN …
New patent expiration for Astrazeneca Ab drug BYDUREON PEN Read Post »
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one…
The post New patent expiration for Astrazeneca Ab drug BYDUREON B…
New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Annual Drug Patent Expirations for QTERNMET+XR Qternmet Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Astrazeneca Ab drug QTERNMET XR appeared fi…
New patent expiration for Astrazeneca Ab drug QTERNMET XR Read Post »
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Boehringer Ingelheim drug OFEV appeared fi…
New patent expiration for Boehringer Ingelheim drug OFEV Read Post »
Annual Drug Patent Expirations for TYKERB Tykerb is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Novartis drug TYKERB appeared first on…
Annual Drug Patent Expirations for MARQIBO+KIT Marqibo Kit is a drug marketed by Acrotech and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Acrotech drug MARQIBO KIT appeared firs…
New patent expiration for Acrotech drug MARQIBO KIT Read Post »
MARQIBO KIT (vincristine sulfate) Acrotech Patent: 7,247,316 Expiration: Sep 25, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Drug…
Drug Patent Expirations for the Week of September 20, 2020 Read Post »
Annual Drug Patent Expirations for MEGACE+ES Megace Es is a drug marketed by Endo Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Endo Pharms drug MEGACE ES appeared first on DrugP…
New patent expiration for Endo Pharms drug MEGACE ES Read Post »